Bain Capital Life Sciences Investors as of June 30, 2021
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 30 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Springworks Therapeutics (SWTX) | 31.5 | $481M | 5.8M | 82.41 | |
Atea Pharmaceuticals (AVIR) | 7.9 | $121M | 5.6M | 21.48 | |
Dynavax Technologies (DVAX) | 7.6 | $116M | 12M | 9.85 | |
Dicerna Pharmaceuticals | 7.5 | $115M | 3.1M | 37.32 | |
Arcutis Biotherapeutics (ARQT) | 7.1 | $109M | 4.0M | 27.29 | |
Annexon (ANNX) | 4.8 | $73M | 3.2M | 22.51 | |
C4 Therapeutics Com Stk (CCCC) | 4.1 | $62M | 1.6M | 37.84 | |
Pharvaris N V (PHVS) | 3.9 | $59M | 3.2M | 18.63 | |
Mersana Therapeutics (MRSN) | 3.3 | $50M | 3.7M | 13.58 | |
Nurix Therapeutics (NRIX) | 2.2 | $34M | 1.3M | 26.53 | |
Crinetics Pharmaceuticals In (CRNX) | 2.1 | $32M | 1.7M | 18.85 | |
Syros Pharmaceuticals | 2.1 | $32M | 5.8M | 5.45 | |
Solid Biosciences | 1.9 | $29M | 7.9M | 3.66 | |
Marinus Pharmaceuticals (MRNS) | 1.7 | $26M | 1.4M | 17.94 | |
Aptinyx | 1.6 | $25M | 8.9M | 2.83 | |
Kymera Therapeutics (KYMR) | 1.5 | $23M | 480k | 48.50 | |
Nautilus Biotechnology (NAUT) | 1.3 | $20M | 2.0M | 10.10 | |
Savara (SVRA) | 1.3 | $20M | 12M | 1.70 | |
Aeglea Biotherapeutics | 1.2 | $19M | 2.7M | 6.96 | |
Bluebird Bio (BLUE) | 1.1 | $17M | 538k | 31.98 | |
X4 Pharmaceuticals (XFOR) | 0.9 | $14M | 2.1M | 6.50 | |
Bctg Acquisition Corp | 0.7 | $11M | 922k | 11.38 | |
Research Alliance Corp Ii Com Cl A | 0.7 | $10M | 1.0M | 10.14 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.5 | $7.5M | 700k | 10.72 | |
Bcls Acquisition Corp Com Cl A | 0.3 | $5.1M | 488k | 10.53 | |
Panacea Acquisition Corp Ii Cl A Shs | 0.3 | $5.0M | 500k | 10.02 | |
Omega Alpha Spac Cl A | 0.3 | $4.0M | 400k | 9.95 | |
Frazier Lifesciences Acqu Unit 12/09/2025 | 0.2 | $3.0M | 300k | 10.05 | |
Jiya Acquisition Corp Com Cl A | 0.2 | $3.0M | 300k | 9.94 | |
Helix Acquisition Corp Com Cl A | 0.2 | $2.6M | 250k | 10.35 |